Grace & White Inc. NY Sells 1,880 Shares of West Pharmaceutical Services, Inc. (NYSE:WST)

Grace & White Inc. NY reduced its stake in West Pharmaceutical Services, Inc. (NYSE:WST - Free Report) by 4.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 41,330 shares of the medical instruments supplier's stock after selling 1,880 shares during the period. West Pharmaceutical Services makes up about 2.2% of Grace & White Inc. NY's investment portfolio, making the stock its 13th biggest holding. Grace & White Inc. NY owned approximately 0.06% of West Pharmaceutical Services worth $12,406,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in WST. Fidelis Capital Partners LLC bought a new position in shares of West Pharmaceutical Services during the first quarter worth about $27,000. Northwest Investment Counselors LLC acquired a new position in shares of West Pharmaceutical Services during the third quarter valued at approximately $30,000. Crewe Advisors LLC grew its position in West Pharmaceutical Services by 322.7% in the second quarter. Crewe Advisors LLC now owns 93 shares of the medical instruments supplier's stock worth $31,000 after buying an additional 71 shares during the last quarter. ORG Partners LLC grew its position in West Pharmaceutical Services by 820.0% in the first quarter. ORG Partners LLC now owns 138 shares of the medical instruments supplier's stock worth $55,000 after buying an additional 123 shares during the last quarter. Finally, Quest Partners LLC grew its position in West Pharmaceutical Services by 5,633.3% in the second quarter. Quest Partners LLC now owns 172 shares of the medical instruments supplier's stock worth $57,000 after buying an additional 169 shares during the last quarter. 93.90% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, VP Charles Witherspoon sold 1,029 shares of the stock in a transaction that occurred on Monday, August 19th. The shares were sold at an average price of $300.00, for a total transaction of $308,700.00. Following the sale, the vice president now directly owns 1,478 shares of the company's stock, valued at $443,400. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.53% of the stock is owned by company insiders.

West Pharmaceutical Services Trading Down 0.3 %

West Pharmaceutical Services stock traded down $0.85 during midday trading on Tuesday, reaching $286.40. The stock had a trading volume of 588,348 shares, compared to its average volume of 550,840. The firm's fifty day simple moving average is $299.90 and its two-hundred day simple moving average is $323.82. West Pharmaceutical Services, Inc. has a twelve month low of $265.00 and a twelve month high of $413.70. The company has a debt-to-equity ratio of 0.03, a current ratio of 2.34 and a quick ratio of 1.68. The firm has a market cap of $20.86 billion, a price-to-earnings ratio of 37.78, a PEG ratio of 10.46 and a beta of 1.01.

West Pharmaceutical Services (NYSE:WST - Get Free Report) last released its quarterly earnings results on Thursday, July 25th. The medical instruments supplier reported $1.52 earnings per share for the quarter, missing analysts' consensus estimates of $1.74 by ($0.22). The business had revenue of $702.10 million for the quarter, compared to the consensus estimate of $729.36 million. West Pharmaceutical Services had a net margin of 18.25% and a return on equity of 19.17%. The firm's revenue for the quarter was down 6.9% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.11 EPS. Equities analysts anticipate that West Pharmaceutical Services, Inc. will post 6.42 EPS for the current fiscal year.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.